We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Quest Laboratories Ltd. is a pharmaceutical company that specializes in the manufacturing of a diverse range of pharmaceutical formulations. The company produces ethical, generic, and over-the-counter (OTC) drugs across various therapeutic segments, including antibiotics, antimalarials, anti-inflammatories, respiratory medications, diabetes treatments, antidepressants, antispasmodics, and antiemetics. These formulations are available in multiple forms such as tablets, liquid orals, dry syrups, powders including Oral Rehydration Salts (ORS), liquid externals, and ointments. Quest Laboratories also manufactures capsules, ampoules, and injections. The company serves target markets including institutional supplies, the domestic ethical market, contract manufacturing clients, and export markets, with a focus on expanding into global regions like North and South Asia.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save QUESTLAB.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
